Abstract Objective: To investigate whether a probiotic supplementation to cART patients modifies the cerebrospinal fluid (CSF) proteome and improves neurocognitive impairment. Methods: 26 CSF samples from 13 HIV-positive patients [six patients living with HIV (PLHIV) and seven patients with a history of AIDS (PHAIDS)] were analyzed. All patients underwent to neurocognitive evaluation and blood sampling at baseline and after 6 months of oral bacteriotherapy. Immune phenotyping and activation markers (CD38 and HLA-DR) were evaluated on peripheral blood mononuclear cells (PBMC). Plasma levels of IL-6, sCD14, and MIP-1β were detected, by enzyme-linked immunosorbent assay (ELISA). Functional proteomic analysis of CSF sample was conducted by two-dimensional electrophoresis; a multivariate analysis was performed by principal component analysis (PCA) and data were enriched by STRING software. Results: Oral bacteriotherapy leads to an improvement on several cognitive test and neurocognitive performance in both groups of HIV-positive subjects. A reduction in the percentage of CD4+CD38+HLA–DR+ T cells was also observed at peripheral level after the probiotic intake (p = 0.008). In addition, the probiotic supplementation to cART significantly modifies protein species composition and abundance at the CSF level, especially those related to inflamma- tion (β2-microglobulin p = 0.03; haptoglobin p = 0.06; albumin p = 0.003; hemoglobin p = 0.003; immunoglobulin heavy chains constant region p = 0.02, transthyretin p = 0.02) in PLHIV and PHAIDS. Conclusions: Our results suggest that oral bacteriotherapy as a supplement to cART could exert a role in the amelioration of inflammation state at peripheral and CNS level.

Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients / Landi, Claudia; Santinelli, Letizia; Bianchi, Laura; Shaba, Enxhi; Ceccarelli, Giancarlo; Cavallari, EUGENIO NELSON; Borrazzo, Cristian; Pinacchio, Claudia; Scagnolari, Carolina; Vullo, Vincenzo; Bini, Luca; D'Ettorre, Gabriella. - In: JOURNAL OF NEUROVIROLOGY. - ISSN 1355-0284. - (2019). [10.1007/s13365-019-00801-7]

Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients

Letizia Santinelli;Laura Bianchi;Giancarlo Ceccarelli
;
Eugenio Nelson Cavallari;Cristian Borrazzo;Claudia Pinacchio;Carolina Scagnolari;Vincenzo Vullo;Gabriella d’Ettorre
2019

Abstract

Abstract Objective: To investigate whether a probiotic supplementation to cART patients modifies the cerebrospinal fluid (CSF) proteome and improves neurocognitive impairment. Methods: 26 CSF samples from 13 HIV-positive patients [six patients living with HIV (PLHIV) and seven patients with a history of AIDS (PHAIDS)] were analyzed. All patients underwent to neurocognitive evaluation and blood sampling at baseline and after 6 months of oral bacteriotherapy. Immune phenotyping and activation markers (CD38 and HLA-DR) were evaluated on peripheral blood mononuclear cells (PBMC). Plasma levels of IL-6, sCD14, and MIP-1β were detected, by enzyme-linked immunosorbent assay (ELISA). Functional proteomic analysis of CSF sample was conducted by two-dimensional electrophoresis; a multivariate analysis was performed by principal component analysis (PCA) and data were enriched by STRING software. Results: Oral bacteriotherapy leads to an improvement on several cognitive test and neurocognitive performance in both groups of HIV-positive subjects. A reduction in the percentage of CD4+CD38+HLA–DR+ T cells was also observed at peripheral level after the probiotic intake (p = 0.008). In addition, the probiotic supplementation to cART significantly modifies protein species composition and abundance at the CSF level, especially those related to inflamma- tion (β2-microglobulin p = 0.03; haptoglobin p = 0.06; albumin p = 0.003; hemoglobin p = 0.003; immunoglobulin heavy chains constant region p = 0.02, transthyretin p = 0.02) in PLHIV and PHAIDS. Conclusions: Our results suggest that oral bacteriotherapy as a supplement to cART could exert a role in the amelioration of inflammation state at peripheral and CNS level.
2019
Probiotic; Functional proteomics; Immunoactivation; Bacteriotherapy
01 Pubblicazione su rivista::01a Articolo in rivista
Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients / Landi, Claudia; Santinelli, Letizia; Bianchi, Laura; Shaba, Enxhi; Ceccarelli, Giancarlo; Cavallari, EUGENIO NELSON; Borrazzo, Cristian; Pinacchio, Claudia; Scagnolari, Carolina; Vullo, Vincenzo; Bini, Luca; D'Ettorre, Gabriella. - In: JOURNAL OF NEUROVIROLOGY. - ISSN 1355-0284. - (2019). [10.1007/s13365-019-00801-7]
File allegati a questo prodotto
File Dimensione Formato  
Landi_Cognitive-impairment_2019.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.26 MB
Formato Adobe PDF
1.26 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1327862
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact